Invention Grant
- Patent Title: Rilpivirine process
- Patent Title (中): 利非韦林过程
-
Application No.: US13880843Application Date: 2012-04-09
-
Publication No.: US08952155B2Publication Date: 2015-02-10
- Inventor: Mukund Keshav Gurjar , Golakchandra Sudarshan Maikap , Shashikant Gangaram Joshi , Sachin Aravind Badhe , Samit Satish Mehta
- Applicant: Mukund Keshav Gurjar , Golakchandra Sudarshan Maikap , Shashikant Gangaram Joshi , Sachin Aravind Badhe , Samit Satish Mehta
- Applicant Address: IN Pune
- Assignee: Emcure Pharmaceuticals Limited
- Current Assignee: Emcure Pharmaceuticals Limited
- Current Assignee Address: IN Pune
- Agency: Blank Rome LLP
- Priority: IN1223/MUM/2011 20110415
- International Application: PCT/IN2012/000246 WO 20120409
- International Announcement: WO2012/143937 WO 20121026
- Main IPC: C07D239/48
- IPC: C07D239/48 ; C07C253/04 ; C07C269/06 ; C07C253/30

Abstract:
Disclosed is process for the preparation of a key Rilpivirine intermediate namely, (E)-4-(2-cyanoethenyl)-2,6-dimethylphenylamine hydrochloride (II) by a process comprising reaction of the tetrafluoroborate salt of the diazonium ion of 2,6-dimethyl-4-amino-1-carboxybenzyl phenylamine (VI) with acrylonitrile in presence of palladium acetate, followed by treatment with an acid and its subsequent conversion to the hydrochloride salt (II), wherein the undesired Z isomer is less than 0.5% and provides Rilpivirine hydrochloride having Z isomer less than 0.1%.
Public/Granted literature
- US20140275538A1 RILPIVIRINE PROCESS Public/Granted day:2014-09-18
Information query